We identified eight major controversial issues in the treatment of APL. These controversial issues include the optimal dose and schedule of both all-trans-retinoic acid and arsenic trioxide, the ...

Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML). With proper treatment, the survival rates are high. APL is a relatively rare cancer, accounting for about 7–8% of ...